title: Long-term complications in Estonian galactosemia patients with a less strict lactose-free diet and metabolic control.
abstract: The main aim of our study was to retrospectively evaluate long-term complications and measure urinary galactose and galactitol excretion in classical galactosemia patients in Estonia who have been treated with a less restricted lactose-free diet and metabolic control. Our study group consisted of five classical galactosemia patients aged 7-14 years and diagnosed since 1996 in Estonia. Their diet eliminates lactose present in dairy foods, but we did not restrict the consumption of mature cheeses, fruits and vegetables. All patients had normal growth, except for one patient who was overweight at the last evaluation. In three patients mental and speech development was normal. One patient, number 1, who was diagnosed latest (at 6 weeks of age), had moderate mental retardation, verbal dyspraxia, extrapyramidal signs and bilateral cataracts. In both patients with developmental problems, a brain MRI showed bilateral subcortical changes in the cerebral white matter. Of four females, only patient 4 (p.Q188R homozygote) has premature ovarian insufficiency. Urinary galactose and galactitol content were retrospectively measured using high-performance liquid chromatography and refractive-index detection from urinary samples that were preserved during the years 1996-2009. Galactose ranged from 60 to 600 mmol/mol creatinine (normal=4-6), and galactitol ranged from 70 to 1200 mmol/mol creatinine (normal=2-4), which was 10-100 and 17-300 times higher than the respective reference ranges for galactose and galactitol. We conclude that a less strict lactose-free diet and metabolic control performed in Estonian classical galactosemia patients does not change long-term outcome compared to previously published studies.
authors.affiliation: Institute of Chemistry, Faculty of Sciences, Tallinn University of Technology, Tallinn, Estonia. kulliki.krabbi@terviseamet.ee
authors.forename: K
authors.initials: K
authors.lastname: Krabbi
authors.forename: M-L
authors.initials: ML
authors.lastname: Uudelepp
authors.forename: K
authors.initials: K
authors.lastname: Joost
authors.forename: R
authors.initials: R
authors.lastname: Zordania
authors.forename: K
authors.initials: K
authors.lastname: Õunap
mesh_terms: D000293:Adolescent; D002648:Child; D004032:Diet; D004957:Estonia; D005260:Female; D004376:Galactitol / Q000652:urine; D005690:Galactose / Q000652:urine; D005693:Galactosemias / Q000178:diet therapy* / Q000503:physiopathology / Q000652:urine; D005838:Genotype; D006801:Humans; D007785:Lactose / Q000009:adverse effects*; D008297:Male; D010641:Phenotype; D012189:Retrospective Studies
chemical_list: D004376:Galactitol; D007785:Lactose; D005690:Galactose